Literature DB >> 11389515

Epidemiology of infections after solid-organ transplantation.

D R Snydman1.   

Abstract

Infections are a major determinant of the outcome of solid-organ transplantation. Their incidence varies because of a number of factors. The type of organ transplanted, the degree of immunosuppression, the need for additional antirejection therapy, and the occurrence of technical or surgical complications all affect the incidence of infection after transplantation. There are 3 general time frames to consider. In the first month, bacterial and candidal infections predominate. From the second through the sixth months, infections "classically" associated with transplantation become manifest. Beyond the sixth month, the clinical course is largely determined by the presence or absence of chronic rejection.

Entities:  

Mesh:

Year:  2001        PMID: 11389515     DOI: 10.1086/320897

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

Review 1.  Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.

Authors:  Michael D Duncan; David S Wilkes
Journal:  Proc Am Thorac Soc       Date:  2005

2.  Defective calcineurin/NFAT signaling in myeloid cells and susceptibility to aspergillosis in post-transplant patients.

Authors:  Seyedmojtaba Seyedmousavi; Michael J Davis
Journal:  Virulence       Date:  2017-12-19       Impact factor: 5.882

3.  Two strategies for prevention of cytomegalovirus infections after liver transplantation.

Authors:  Philipp Simon; Max Sasse; Sven Laudi; David Petroff; Michael Bartels; Udo X Kaisers; Sven Bercker
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

4.  Tacrolimus (FK506): Safety and Applications in Reconstructive Surgery.

Authors:  Thomas H Tung
Journal:  Hand (N Y)       Date:  2009-04-11

5.  Risk factors for early viral infections after liver transplantation.

Authors:  Cornelius Johannes Busch; Benedikt Hermann Siegler; Heike Werle; Christoph Lichtenstern; Thomas Bruckner; Alexandra Heininger; Arianeb Mehrabi; Karl Heinz Weiss; Markus Alexander Weigand; Marcel Hochreiter
Journal:  Langenbecks Arch Surg       Date:  2018-04-25       Impact factor: 3.445

6.  Cyclosporine A impairs nucleotide binding oligomerization domain (Nod1)-mediated innate antibacterial renal defenses in mice and human transplant recipients.

Authors:  Emilie Tourneur; Sanae Ben Mkaddem; Cécilia Chassin; Marcelle Bens; Jean-Michel Goujon; Nicolas Charles; Christophe Pellefigues; Meryem Aloulou; Alexandre Hertig; Renato C Monteiro; Stephen E Girardin; Dana J Philpott; Eric Rondeau; Carole Elbim; Catherine Werts; Alain Vandewalle
Journal:  PLoS Pathog       Date:  2013-01-31       Impact factor: 6.823

7.  Treatment of multidrug-resistant gram-negative bacilli after solid organ transplant: Outcomes and complications.

Authors:  Madeleine R Heldman; Kexin Guo; Brett Nelson; Tenzin Babu; Michael G Ison
Journal:  Transpl Infect Dis       Date:  2020-10-07

8.  Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus.

Authors:  Rodney Arcenas; Raymond H Widen
Journal:  BMC Microbiol       Date:  2002-07-23       Impact factor: 3.605

9.  Infectious complications following heart transplantation in the era of high-priority allocation and extracorporeal membrane oxygenation.

Authors:  Stéphanie Pons; Romain Sonneville; Lila Bouadma; Lenka Styfalova; Stéphane Ruckly; Mathilde Neuville; Aguila Radjou; Jordane Lebut; Marie-Pierre Dilly; Bruno Mourvillier; Richard Dorent; Patrick Nataf; Michel Wolff; Jean-François Timsit
Journal:  Ann Intensive Care       Date:  2019-01-25       Impact factor: 6.925

Review 10.  Periodontitis Impact in Interleukin-6 Serum Levels in Solid Organ Transplanted Patients: A Systematic Review and Meta-Analysis.

Authors:  Vanessa Machado; João Botelho; Joana Lopes; Mariana Patrão; Ricardo Alves; Leandro Chambrone; Gil Alcoforado; José João Mendes
Journal:  Diagnostics (Basel)       Date:  2020-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.